Terazosin Hydrochloride
- Product NDC
- 71335-2125
- 11-digit product format
- 713352125
- Labeler code
- 71335
- Product ID
- 71335-2125_b486acff-84fd-44ee-a454-35dcc2a7fcb5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA074823
- Marketing category
- ANDA
- Marketing start
- 2020-06-30
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-2125-1 | 71335212501 | 30 CAPSULE in 1 BOTTLE (71335-2125-1) | 30 capsule | 2022-07-18 | 0000-00-00 | No | No | Current |
| 71335-2125-2 | 71335212502 | 28 CAPSULE in 1 BOTTLE (71335-2125-2) | 28 capsule | 2022-07-18 | 0000-00-00 | No | No | Current |
| 71335-2125-3 | 71335212503 | 90 CAPSULE in 1 BOTTLE (71335-2125-3) | 90 capsule | 2022-07-18 | 0000-00-00 | No | No | Current |